TABLE 3.
Examples of pharmacy practice acts related to provision of follow-up care by a pharmacist
| Type of prescriptive authority | Characteristic(s) | Example state |
|---|---|---|
| Prohibited | CPAs are not authorized or may not allow for a diagnostic component | Delaware |
| Most restrictive | ||
| Patient-specific CPA | Initiation and modification of drug therapy are allowed under a CPA if the patient is under the care of the signing prescriber | Illinois |
| Limited value for acute conditions | ||
| Population CPA | A single prescriber can authorize a pharmacist to initiate and modify drug therapy for any patient that meets criteria set forth in the CPA | Michigan |
| Allows for management of patient with acute conditions | ||
| Population CPA with specifications | States may limit the conditions to be managed under the CPA (e.g., influenza and group A streptococcal pharyngitis) | Kentucky |
| Statewide protocol | Authorization granted by a protocol approved by the state and signed by an authorizing prescriber | |
| Many states authorize the dispensing of naloxone by protocol | ||
| Currently, no states authorize management of patients with infectious conditions by protocol | ||
| Unrestricted (category specific) | Idaho Prescriptive authority for a limited range of medications | |
| Least restrictive | ||